With the threat of an avian flu pandemic lingering, the search for agents with prophylactic or therapeutic potential continues. Now, Antonio Lanzavecchia (Institute for Research in Biomedicine, Switzerland), Kanta Subbarao (National Institutes of Health, Bethesda, MD), and colleagues report that neutralizing antibodies from humans who had recovered from avian flu (H5N1) protected mice against H5N1 infection.
Lab Anim. (NY) 36, 9 (2007).
Fluent in Science 